Literature DB >> 11442276

Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice.

T Jung1, W Kamm, A Breitenbach, K D Hungerer, E Hundt, T Kissel.   

Abstract

PURPOSE: Aim of the study was the evaluation of the potential of novel tetanus toxoid (TT) loaded nanoparticles (NP) for electing an immune response in mice against TT.
METHODS: Six week-old female Balb/c mice were immunized by oral (p.o.), nasal (i.n.) and intraperitoneal (i.p.) application of TT NP loaded by adsorption. As polymer a novel polyester, sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide), SB(43)-PVAL-g-PLGA was used. Blood samples were collected 4 and 6 weeks after immunization and assayed for serum IgG- as well as IgA antibody titers by ELISA. NP formulations varying in size and loading were compared to alum adsorbates as well as to TT solutions.
RESULTS: Both, p.o. and i.n. administration of TT associated NP increased serum titers up to 3 x 10(3) (IgG) and 2 x 10(3) (IgA). While small NP induced significantly higher titers then larger ones after oral administration, intermediate NP induced antibodies after nasal application. Of the mucosal routes investigated, i.n. seems to be more promising compared to p.o. immunization.
CONCLUSIONS: Antigen loaded NP prepared from surface modified polyesters combined with CT show considerable potential as a vaccine delivery system for mucosal immunization. The results warrant further experiments to explore in more detail the potential use of NP as mucosal vaccine delivery system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11442276     DOI: 10.1023/a:1011063232257

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  24 in total

Review 1.  The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual.

Authors:  A T Florence
Journal:  Pharm Res       Date:  1997-03       Impact factor: 4.200

Review 2.  Nasal delivery of vaccines.

Authors:  A J Almeida; H O Alpar
Journal:  J Drug Target       Date:  1996       Impact factor: 5.121

Review 3.  Adsorption of proteins from solution at the solid-liquid interface.

Authors:  W Norde
Journal:  Adv Colloid Interface Sci       Date:  1986-09       Impact factor: 12.984

4.  Biodegradable microspheres: vaccine delivery system for oral immunization.

Authors:  J H Eldridge; R M Gilley; J K Staas; Z Moldoveanu; J A Meulbroek; T R Tice
Journal:  Curr Top Microbiol Immunol       Date:  1989       Impact factor: 4.291

Review 5.  Oral tolerance.

Authors:  T B Tomasi
Journal:  Transplantation       Date:  1980-05       Impact factor: 4.939

6.  Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit.

Authors:  M Isaka; Y Yasuda; S Kozuka; Y Miura; T Taniguchi; K Matano; N Goto; K Tochikubo
Journal:  Vaccine       Date:  1998-10       Impact factor: 3.641

7.  Oral vaccine models: multiple delivery systems employing tetanus toxoid.

Authors:  R J Jackson; H F Staats; J Xu-Amano; I Takahashi; H Kiyono; M E Hudson; R M Gilley; S N Chatfield; J R McGhee
Journal:  Ann N Y Acad Sci       Date:  1994-08-15       Impact factor: 5.691

8.  Immune response to nasal delivery of antigenically intact tetanus toxoid associated with poly(L-lactic acid) microspheres in rats, rabbits and guinea-pigs.

Authors:  A J Almeida; H O Alpar; M R Brown
Journal:  J Pharm Pharmacol       Date:  1993-03       Impact factor: 3.765

9.  Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency.

Authors:  P Jani; G W Halbert; J Langridge; A T Florence
Journal:  J Pharm Pharmacol       Date:  1990-12       Impact factor: 3.765

10.  Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen.

Authors:  C O Elson; W Ealding
Journal:  J Immunol       Date:  1984-12       Impact factor: 5.422

View more
  27 in total

1.  Novel chitosan particles and chitosan-coated emulsions inducing immune response via intranasal vaccine delivery.

Authors:  Takahiro Nagamoto; Yoshiyuki Hattori; Kozo Takayama; Yoshie Maitani
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

Review 2.  Physical and chemical strategies for therapeutic delivery by using polymeric nanoparticles.

Authors:  José M Morachis; Enas A Mahmoud; Adah Almutairi
Journal:  Pharmacol Rev       Date:  2012-04-27       Impact factor: 25.468

3.  Relationship between the size of nanoparticles and their adjuvant activity: data from a study with an improved experimental design.

Authors:  Xinran Li; Brian R Sloat; Nijaporn Yanasarn; Zhengrong Cui
Journal:  Eur J Pharm Biopharm       Date:  2010-12-21       Impact factor: 5.571

Review 4.  Past, present, and future technologies for oral delivery of therapeutic proteins.

Authors:  Rajesh Singh; Shailesh Singh; James W Lillard
Journal:  J Pharm Sci       Date:  2008-07       Impact factor: 3.534

Review 5.  Applications of nanomaterials as vaccine adjuvants.

Authors:  Motao Zhu; Rongfu Wang; Guangjun Nie
Journal:  Hum Vaccin Immunother       Date:  2014-11-17       Impact factor: 3.452

Review 6.  Technologies to improve immunisation safety.

Authors:  C J Clements; M T Aguado; L Jódar
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

7.  Preparation and characterization of innovative protein-coated poly(methylmethacrylate) core-shell nanoparticles for vaccine purposes.

Authors:  Rebecca Voltan; Arianna Castaldello; Egidio Brocca-Cofano; Giuseppe Altavilla; Antonella Caputo; Michele Laus; Katia Sparnacci; Barbara Ensoli; Silvia Spaccasassi; Marco Ballestri; Luisa Tondelli
Journal:  Pharm Res       Date:  2007-05-03       Impact factor: 4.200

8.  Stability of proteins encapsulated in injectable and biodegradable poly(lactide-co-glycolide)-glucose millicylinders.

Authors:  Jichao Kang; Oliver Lambert; Michael Ausborn; Steven P Schwendeman
Journal:  Int J Pharm       Date:  2008-02-14       Impact factor: 5.875

9.  Polymer chemistry influences monocytic uptake of polyanhydride nanospheres.

Authors:  Bret D Ulery; Yashdeep Phanse; Avanti Sinha; Michael J Wannemuehler; Balaji Narasimhan; Bryan H Bellaire
Journal:  Pharm Res       Date:  2008-11-06       Impact factor: 4.200

Review 10.  Materials for pharmaceutical dosage forms: molecular pharmaceutics and controlled release drug delivery aspects.

Authors:  Heidi M Mansour; Minji Sohn; Abeer Al-Ghananeem; Patrick P Deluca
Journal:  Int J Mol Sci       Date:  2010-09-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.